Biotechnology

Techseriesinsight > Blog > News > Biotechnology

March 4, 2026
PRNewswire
Biotechnology, News

HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Inhibitor Program at 15th European Lupus Meeting

HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, allosteric small molecules that target natural regulatory pockets, today announced the presentation of preclinical data from...

March 4, 2026
Business Wire
Biotechnology, News

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KalVista Pharmaceuticals, Inc. today announced that the Compensation Committee of KalVista’s Board of Directors granted one newly-hired employee inducement options to purchase an aggregate of 6,750 shares of KalVista...

March 2, 2026
Business Wire
Biotechnology, News

Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening

Wisdom Bioscience, Inc., a biotechnology company pioneering non-invasive oral cancer diagnostics, today announced the formation of its Scientific Advisory Board (SAB) following the close of an initial funding round....

February 27, 2026
Business Wire
Biotechnology, News

Zura Bio Closes $144 Million Public Offering to Advance Autoimmune Pipeline

Zura Bio Public Offering Raises $144 Million in Gross Proceeds The Zura Bio public offering has officially closed, raising approximately $144 million in gross proceeds to support the company’s...

February 27, 2026
Business Wire
Biotechnology, News

Cowellnex and Metagen Launch Joint Research on Gut Microbiota Testing

Gut microbiota testing is entering a new phase in Japan as Cowellnex Co., Ltd. and Metagen, Inc. announce a joint research initiative starting in February 2026. The partnership aims...

February 26, 2026
Business Wire
Biotechnology, News

Niagen Bioscience Sells ChromaDex Reference Standards Business to LGC in All-Cash Deal

Niagen Bioscience, Inc. has announced the sale of its ChromaDex Reference Standards business to LGC in an all-cash transaction completed on February 24, 2026. The move allows Niagen Bioscience...

February 26, 2026
Business Wire
Biotechnology, News

Compass Pathways Warrants Exercise Raises $200 Million

Compass Pathways plc (Nasdaq: CMPS) has announced the exercise of outstanding warrants, generating approximately $200 million in gross proceeds. The financing milestone strengthens the company’s balance sheet and supports...

February 26, 2026
PRNewswire
Biotechnology, News

CJ BIO Publishes Clinical Study on BiomeNrich™ POST SZ075 Postbiotic

CJ BIO has published new clinical findings on BiomeNrich™ POST SZ075, reinforcing its position in the growing inner beauty market. The study appeared in the peer-reviewed journal Food Science...

February 26, 2026
PRNewswire
Biotechnology, News

genO-hFcγR Mouse Model Improves Antibody Therapy Prediction

Antibody therapies are transforming the treatment of cancer, inflammatory diseases, and infectious disorders. However, many promising drug candidates fail during late-stage clinical trials. A new study published in Science...

February 25, 2026
PRNewswire
Biotechnology, News

Scinai Immunotherapeutics Ltd. Secures Expanded IIA Support for Robotic Aseptic Fill & Finish Platform

Scinai IIA support has been expanded following an additional review by the Israel Innovation Authority (IIA). Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) announced that its robotic aseptic fill & finish...